Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041093
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-07-08
Brief Title:
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Study Overview
Official Title:
A Phase II Evaluation Of Docetaxel NSC 628503 In The Treatment Of Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase II trial to study the effectiveness of docetaxel in treating patients who have persistent or recurrent cervical cancer Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
Detailed Description:
PRIMARY OBJECTIVES
I Determine the antitumor activity of docetaxel in patients with persistent or recurrent squamous cell carcinoma of the cervix
II Determine the toxicity of this drug in these patients
OUTLINE This is a multicenter study
Patients receive docetaxel IV over 1 hour on day 1 Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity
Patients are followed every 3 months for 2 years every 6 months for 3 years and then annually thereafter
I Determine the antitumor activity of docetaxel in patients with persistent or recurrent squamous cell carcinoma of the cervix
II Determine the toxicity of this drug in these patients
OUTLINE This is a multicenter study
Patients receive docetaxel IV over 1 hour on day 1 Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity
Patients are followed every 3 months for 2 years every 6 months for 3 years and then annually thereafter
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2012-02476 | REGISTRY | None | None |
| CDR0000069442 | None | None | None |
| GOG-0127S | OTHER | None | None |
| GOG-0127S | OTHER | None | None |
| U10CA027469 | NIH | CTEP | httpsreporternihgovquickSearchU10CA027469 |